nach oben

Erschienen in:

23.10.2018 | Original Paper

Optimization of Antipsychotic and Benzodiazepine Drugs in Patients with Severe Mental Disorders in an Intensive Case Management Program

verfasst von: María-José Alvarez, Pere Roura-Poch, Nùria Riera, Ana Martín, Clara Blanch, Judit Pons, Josep-Manel Santos, Santiago Escoté

Erschienen in: Community Mental Health Journal | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

The Intensive Case Management (ICM) model is a community-based program for people with severe mental illness that may reduce hospitalization and increase retention in care. The aims of this study were to analyze changes in the antipsychotic and benzodiazepine dosage in 106 patients who participated in an Individualized Service Program based on the ICM model for at least 6 months and to assess the change in the number of patients taking a high or very high dose of an antipsychotic drug and the number receiving antipsychotic polytherapy. Both the average daily dose of antipsychotic and benzodiazepine drugs and the number of patients with high doses of antipsychotic and more than one antipsychotic drug decreased significantly. Implementing the ICM program in patients with severe mental illness could help to decrease adverse drug effects and health care expenditures.

Barnes, T. R., & Paton, C. (2011). Antipsychotic polypharmacy in schizophrenia: Benefits and risks. CNS Drugs, 25(5), 383–399.CrossRefPubMed

Behavioural Health Planning Council. (2003). Assertive Community Treatment workbook. Retrieved from http://www.wvmhpc.org/docs/ACT_workbook.pdf.

Burns, T., Catty, J., Dash, M., Roberts, C., Lockwood, A., & Marshall, M. (2007). Use of intensive case management to reduce time in hospital in people with severe mental illness: Systematic review and meta-regression. BMJ, 335, 336.CrossRefPubMedPubMedCentral

Canadian Agency for Drugs and Technologies in Health. (2012). Combination and high-dose atypical antipsychotic therapy in patients with schizophrenia: Systematic review. CADTH Technology Overviews, 2(3), e2301.

Clark, R., Bartels, S., Mellman, T., & Peacock, W. (2002). Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: Implications for state mental health policy. Schizophrenia Bulletin, 28, 75–84.CrossRefPubMed

Consell Assessor sobre Assistència Psiquiàtrica i Salut Mental (2003). Pla de serveis individualitzats (PSI). Barcelona: Servei Català de la Salut.

Constantine, R. J., Andel, R., McPherson, M., & Tandon, R. (2015). The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: A randomized controlled trial. Schizophrenia Research, 166, 194–200.CrossRefPubMed

Dieterich, M., Irving, C. B., Bergman, H., Khokhar, M. A., Park, B., & Marshall, M. (2017). Intensive case management for severe mental illness. Schizophrenia Bulletin, 43(4), 698–700.CrossRefPubMedPubMedCentral

Dold, M., Li, C., Gillies, D., & Leucht, S. (2013). Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and Cochrane review of randomized controlled trials. European Neuropsychopharmacology, 23(9), 1023–1033.CrossRefPubMed

Gardner, D. M., Murphy, A. L., O’Donnell, H., Centorrino, F., & Baldessarini, R. J. (2010). International consensus study of antipsychotic dosing. American Journal of Psychiatry, 167(6), 686–693.CrossRefPubMed

Garety, P., Fowler, D., & Kuipers, E. (2000). Cognitive-behavioral therapy for medication-resistant symptoms. Schizophrenia Bulletin, 26, 73–86.CrossRefPubMed

Hoult, J. (1986). Community care of the acutely mentally ill. The British Journal of Psychiatry, 149, 137–144.CrossRefPubMed

Killaspy, H., Bebbington, P., Blizard, R., Johnson, S., Nolan, F., Pilling, S., et al. (2006). The REACT study: Randomised evaluation of assertive community treatment in North London. British Medical Journal, 332, 815–820.CrossRefPubMed

Kroken, R. A., Johnsen, E., Ruud, T., Wentzel-Larsen, T., & Jørgensen, H. A. (2009). Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry, 9, 24.CrossRefPubMedPubMedCentral

Lehman, A. F., Lieberman, J. A., Dixon, L. B., McGlashan, T. H., Miller, A. L., Perkins, D. O., et al. (2004). Practice guideline for the treatment of patients with schizophrenia, second edition. American Journal of Psychiatry, 161(2 Suppl), 1–56.PubMed

Marshall, M., Gray, A., Lockwood, A., & Green, R. (2000). Case management for people with severe mental disorders. Cochrane Database of Systematic Reviews, 2, CD000050.

National Collaborating Centre for Mental Health. (2009). Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. Leicester: British Psychological Society.

National Health Service Foundation Trust. (2012). High dose antipsychotic therapy guideline. London: Humber NHS.

Nielsen, J., Le Quach, P., Emborg, C., Foldager, L., & Correll, C. U. (2010). 10-Year trends in the treatment and outcomes of patients with first-episode schizophrenia. Acta Psychiatrica Scandinavica, 122, 356–366.CrossRefPubMed

Rathod, S., Kingdon, D., Weiden, P., & Turkington, D. (2008). Cognitive-behavioral therapy for medication-resistant schizophrenia: A review. Journal of Psychiatric Practice, 14, 1022–1033.CrossRef

Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009). Atypical antipsychotic drugs and the risk of sudden cardiac death. New England Journal of Medicine, 360(3), 225–235.CrossRefPubMed

Satake, N., Hazama, K., Sono, T., Takashashi, M., & Ito, J. (2011). Changes in antipsychotic medication in clients of assertive community treatment in Japan: A one-year follow up. Clinical Practice and Epidemiology in Mental Health, 7, 1–3.CrossRefPubMedPubMedCentral

Stein, L. I., & Test, M. A. (1980). Alternative to mental hospital treatment. Conceptual model, treatment program, and clinical evaluation. Archives of General Psychiatry, 37(4), 392–397.CrossRef

Sytema, S., Wunderink, L., Bloemers, W., Roorda, L., & Wiersma, D. (2007). Assertive community treatment in the Netherlands: A randomized controlled trial. Acta Psychiatrica Scandinavica, 116, 105–112.CrossRefPubMed

Torniainen, M., Mittendorfer-Rutz, E., Tanskanen, A., Björkenstam, C., Suvisaari, J., Alexanderson, K., et al. (2015). Antipsychotic treatment and mortality in schizophrenia. Schizophrenia Bulletin, 41(3), 656–663.CrossRefPubMed

Villa Alcazar, L. F., & Esteban Calvo, C. (2011). Medimecum. Guía de terapia farmacológica. Madrid: Adis.

Yamanouchi, Y., Sukegawa, T., Inagaki, A., Inada, T., Yoshio, T., Yoshimura, R., et al. (2015). Evaluation of the individual safe correction of antipsychotic agent polypharmacy in japanese patients with chronic schizophrenia. Validation of safe corrections for antipsychotic polypharmacy and the high-dose method. International Journal of Neuropsychopharmacology, 18, 1–8.CrossRef

Titel: Optimization of Antipsychotic and Benzodiazepine Drugs in Patients with Severe Mental Disorders in an Intensive Case Management Program
verfasst von: María-José Alvarez
Pere Roura-Poch
Nùria Riera
Ana Martín
Clara Blanch
Judit Pons
Josep-Manel Santos
Santiago Escoté
Publikationsdatum: 23.10.2018
Verlag: Springer US
Erschienen in: Community Mental Health Journal / Ausgabe 5/2019
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-018-0349-2

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Optimization of Antipsychotic and Benzodiazepine Drugs in Patients with Severe Mental Disorders in an Intensive Case Management Program

Abstract

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

Perspectives on Suicide Prevention Amongst Members of Christian Faith-Based Organizations

A University-Based Transdisciplinary Approach to Mental Health Workforce Shortages

Affirmative Competence and Practices of Mental Health Professionals with LGB clients: An Ibero-American Study

The Cost-Effectiveness of the Improving Access to Psychological Therapies (IAPT) Programme in Severe Mental Illness: A Decision Analytical Model Using Routine Data

Predicting Turnover: The Moderating Effect of Functional Climates on Emotional Exhaustion and Work Attitudes

Between the Inside and the Outside World: Coping of Ultra-Orthodox Individuals with Their Work Environment After Academic Studies

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie